You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anagrelide

Showing 1 - 25 of 35
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Rueil-Malmaison (Anagrelide 0.5 mg, Anagrelide 2.5 mg, Moxifloxacin)

Completed
Has Results
  • Healthy
  • Anagrelide 0.5 mg
  • +3 more
  • Rueil-Malmaison, France
    Biotrial
May 24, 2021

Essential Thrombocythaemia Trial in Spain, Sweden, United Kingdom (anagrelide HCl)

Completed
Has Results
  • Essential Thrombocythaemia
  • anagrelide hydrochloride
  • Barcelona, Spain
  • +4 more
Jun 7, 2021

Essential Thrombocythemia Trial (Bomedemstat, Anagrelide, Busulfan)

Not yet recruiting
  • Essential Thrombocythemia
  • (no location specified)
Oct 6, 2023

Patients With ET Treated With XAGRID®

Completed
Has Results
  • Essential Thrombocythemia (ET)
  • Anagrelide hydrochloride
  • Bari, Italy
  • +9 more
Jul 6, 2021

MPN (Myeloproliferative Tumors) Trial in United States (Ruxolitinib, Anagrelide, Placebo)

Terminated
Has Results
  • MPN (Myeloproliferative Neoplasms)
  • Phoenix, Arizona
  • +25 more
Oct 21, 2021

Thrombocythemia, Hemorrhagic Trial in Worldwide (Anagrelide, Hydroxyurea)

Completed
Has Results
  • Thrombocythemia, Hemorrhagic
  • Pleven, Bulgaria
  • +14 more
May 13, 2021

Essential Thrombocythemia Trial in Tours (Anagrelide, Ruxolitinib (JAKAVI®), IFNa/ PegIFNa)

Terminated
  • Essential Thrombocythemia
  • Anagrelide
  • +2 more
  • Tours, France
    FILO
Jun 28, 2021

Essential Thrombocythemia Trial in Worldwide (Ropeginterferon alfa-2b, Anagrelide)

Recruiting
  • Essential Thrombocythemia
  • Ropeginterferon alfa-2b
  • Anagrelide
  • Phoenix, Arizona
  • +60 more
Dec 30, 2021

Essential Thrombocythemia Trial in Korea, Republic of (Anagre Cap.)

Completed
  • Essential Thrombocythemia
  • Anagre Cap.
  • Goyang, Gyeonggi, Korea, Republic of
  • +20 more
Jul 20, 2021

Xagrid (FOX) Study In Adult Essential Thrombocythemia

Completed
Has Results
  • Essential Thrombocythemia
    • Paris, Cedex 13, France
    • +45 more
    Jun 7, 2021

    Polycythemia Vera (PV) Trial in Japan (P1101 (Ropeginterferon alfa-2b))

    Recruiting
    • Polycythemia Vera (PV)
    • P1101 (Ropeginterferon alfa-2b)
    • Toon-shi, Ehime, Japan
    • +5 more
    Jun 13, 2022

    Myelofibrosis Trial in Worldwide (Selinexor, Physician's Choice Treatment)

    Recruiting
    • Myelofibrosis
    • Los Angeles, California
    • +41 more
    Jan 30, 2023

    Chronic Myeloid Leukemia Trial in Italy (Nilotinib)

    Completed
    • Chronic Myeloid Leukemia
    • Ascoli Piceno, Italy
    • +21 more
    Jan 3, 2022

    Polycythemia Vera (PV), Essential Thrombocythemia (ET) Trial in Germany (Ruxolitinib, BAT)

    Active, not recruiting
    • Polycythemia Vera (PV)
    • Essential Thrombocythemia (ET)
    • Mannheim, Baden-Württemberg, Germany
    • +23 more
    Oct 6, 2020

    Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)

    Recruiting
    • Myeloproliferative Disorders
    • +4 more
    • La Jolla, California
    • +184 more
    Aug 22, 2022

    Polycythemia Vera In US Clinical Practices (REVEAL)

    Completed
    • MPN (Myeloproliferative Neoplasms)
      • Green Valley, Arizona
      • +265 more
      Apr 22, 2021

      Leukemia Trial in Worldwide (Dasatinib)

      Completed
      Has Results
      • Leukemia
      • Vienna, Austria
      • +12 more
      Feb 24, 2021

      Primary Myelofibrosis (PMF), Post-polycythemia Vera (Post-PV), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF) Trial

      Completed
      • Primary Myelofibrosis (PMF)
      • +2 more
      • Los Angeles, California
      • +47 more
      Apr 1, 2020

      Polycythemia Vera Trial in Worldwide (ruxolitinib tablets, Best Available Therapy (BAT))

      Completed
      Has Results
      • Polycythemia Vera
      • ruxolitinib tablets
      • Best Available Therapy (BAT)
      • Birmingham, Alabama
      • +101 more
      Feb 8, 2019

      Polycythemia Vera Trial in Worldwide (Best Available Therapy, Ruxolitinib)

      Completed
      Has Results
      • Polycythemia Vera
      • Herston, Queensland, Australia
      • +47 more
      Jun 29, 2021

      Polycythemia Vera, Essential Thrombocythemia Trial in Washington, New York, Winston-Salem (RG7388, Pegasys)

      Completed
      • Polycythemia Vera
      • Essential Thrombocythemia
      • Washington, District of Columbia
      • +2 more
      Sep 11, 2019

      Thrombocytosis, Myeloproliferative Tumors Trial in United States (Anagrelide CR)

      Completed
      • Thrombocytosis
      • Myeloproliferative Neoplasms
      • Anagrelide CR
      • Burbank, California
      • +10 more
      Feb 23, 2017

      High Risk Polycythemia Vera, High Risk Essential Thrombocythemia Trial in Worldwide (PEGASYS, Hydroxyurea, Aspirin)

      Completed
      Has Results
      • High Risk Polycythemia Vera
      • High Risk Essential Thrombocythemia
      • Scottsdale, Arizona
      • +24 more
      Apr 16, 2019

      Essential Thrombocythaemia Trial in Worldwide (Anagrelide retard, Placebo)

      Completed
      • Essential Thrombocythaemia
      • Anagrelide retard
      • Placebo
      • Innsbruck, Austria
      • +36 more
      May 25, 2016

      Essential Thrombocythemia Trial in Worldwide (Anagrelide retard, Thromboreductin)

      Completed
      • Essential Thrombocythemia
      • Linz, Austria
      • +18 more
      Jul 27, 2015